Cargando…
Nrf2 protects stellate cells from Smad-dependent cell activation
Hepatic stellate cells (HSC) orchestrate the deposition of extracellular matrix (ECM) and are the primary effector of liver fibrosis. Several factors, including TGF-β1, PDGF and oxidative stress, have been shown to trigger HSC activation. However, the involvement of cellular defence mechanisms, such...
Autores principales: | Prestigiacomo, Vincenzo, Suter-Dick, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054401/ https://www.ncbi.nlm.nih.gov/pubmed/30028880 http://dx.doi.org/10.1371/journal.pone.0201044 |
Ejemplares similares
-
Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis
por: Prestigiacomo, Vincenzo, et al.
Publicado: (2017) -
SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells
por: Zhong, Xiaolin, et al.
Publicado: (2020) -
MicroRNA-195 Activates Hepatic Stellate Cells In Vitro by Targeting Smad7
por: Song, Li-Ying, et al.
Publicado: (2017) -
Tetramethylpyrazine inhibits CTGF and Smad2/3 expression and proliferation of hepatic stellate cells
por: Li, Jun, et al.
Publicado: (2015) -
Xiaochaihutang Inhibits the Activation of Hepatic Stellate Cell Line T6 Through the Nrf2 Pathway
por: Hu, Rui, et al.
Publicado: (2019)